Not Yet RecruitingNot Applicable

18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients

59 participantsStarted 2026-05-01

Plain-language summary

To compare the diagnostic performance of 18-F PSMA PET/CT and CT alone in initial staging, assessment of therapy response, as well as evaluation of biochemical recurrence of prostatic cancer patients The main question it aims to answer is: Does 18-F PSMA PET/CT have a superior role over CT in evaluation of prostatic cancer patients?

Who can participate

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients with known prostate cancer referred for 18-F PSMA PET/CT study Exclusion Criteria: * Patients with claustrophobia * Patients refuse to do the scan

What they're measuring

Comparing 18-F PSMA PET/CT and CT in evaluation of prostatic cancer patients

Timeframe: 2 years

Trial details

NCT IDNCT07485881

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-05

Contact for this trial

Maram Shafeek, MSc

+201019050584 maram.mostafa996@gmail.com

View on ClinicalTrials.gov More Prostate Cancer trials